Tech Company Financing Transactions

ProThera Biologics Funding Round

ProThera Biologics, based in East Providence, secured $250 thousand from Slater Technology Fund.

Transaction Overview

Company Name
Announced On
9/30/2012
Transaction Type
Venture Equity
Amount
$250,000
Round
Undisclosed
Investors

Slater Technology Fund (Richard Horan)

Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
349 Eddy St.
East Providence, RI 02903
USA
Email Address
Overview
The mission of the company is to develop novel products that exploit the promise of personalized medicine by leveraging on its proprietary technology of natural serine protease inhibitor proteins.
Profile
ProThera Biologics LinkedIn Company Profile
Social Media
ProThera Biologics Company Twitter Account
Company News
ProThera Biologics News
Facebook
ProThera Biologics on Facebook
YouTube
ProThera Biologics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Yow-Pin Lim
  Yow-Pin Lim LinkedIn Profile  Yow-Pin Lim Twitter Account  Yow-Pin Lim News  Yow-Pin Lim on Facebook
President
Denice Spero
  Denice Spero LinkedIn Profile  Denice Spero Twitter Account  Denice Spero News  Denice Spero on Facebook


 

 

Browse more venture capital transactions:

Prev: 9/30/2012: Instructure venture capital transaction
Next: 9/30/2012: Purfresh venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary